Drugs inhibiting SLC7A11 gene could have great therapeutic potential, as demonstrated by in vitro and vivo studies in breast cancer [32] and resistant head and neck cancer cells [33] using the SLC7A11 inhibitors. The gene discussed is SLC7A11; the disease is head and neck cancer.